GlassScriptPhysician profile
Holly Gates
NPI 1063991206
$6,305.21
in general payments reported to CMS, 2019-2025
42 companies · $1,502 in 2025
The $1,502 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $601 · 2022: $1,297 · 2023: $1,177 · 2024: $1,729 · 2025: $1,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,395 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,395.46 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,183.70 | 2021-2025 | |
| Lilly USA, LLC | $1,067.50 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $635.52 | 2022-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $630.36 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Indivior INC. | $426.05 | 2023-2025 | Sublocade |
| Novo Nordisk INC | $334.27 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $256.73 | 2021-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $239.66 | 2021-2025 | |
| Amgen INC. | $150.20 | 2021-2024 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.21 | 2021-2025 | Xifaxan |
| Exact Sciences Corporation | $119.44 | 2023-2025 | Cologuard Collection Kit |
| Viiv Healthcare Company | $104.25 | 2024-2025 | Apretude |
| Merck Sharp & Dohme LLC | $101.80 | 2021-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Vertex Pharmaceuticals Incorporated | $94.36 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $79.30 | 2022-2024 | Gvoke Hypopen |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.